Hepatitis C symptoms and diagnosis: latest news

Hepatitis C symptoms and diagnosis resources

  • Hepatitis C

    A blood test for antibodies will show if you have been exposed to hepatitis C.HIV treatment has particular benefits for people with HIV and hepatitis...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, though the two viruses are not related. Recent estimates find that...

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1

Hepatitis C symptoms and diagnosis features

Hepatitis C symptoms and diagnosis in your own words

Hepatitis C symptoms and diagnosis news from aidsmap

More news

Hepatitis C symptoms and diagnosis news selected from other sources

  • Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes

    Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

    23 October 2017 | AASLD
  • Hep C: An end in sight?

    Despite its prevalence, hepatitis C has long been under-prioritised by health services. But could new drugs and a new commitment from the NHS mean we may finally see this killer condition eradicated?

    05 October 2017 | Drink & Drug News
  • Targeting MSM with HIV: Treatment as Prevention in the Netherlands

    As part of Dutch HIV guidelines, all individuals with HIV are screened for hepatitis C. Anne Boerekamps, MD, of Erasmus University Medical Center in Rotterdam, the Netherlands, spoke with HCV Next about the Dutch approach, the relevant data, and other topics associated with screening and treating MSM.

    18 July 2017 | Healio Hepatology
  • Charity calls for new focus to combat Hep C infections in Scotland

    A charity has called for greater efforts to eliminate Hepatitis C (HCV) from Scotland. There are about 37,000 people living with the virus - but campaigners say as many again are undiagnosed.

    27 June 2017 | BBC
  • Hepatic steatosis worsens faster in HIV mono-infection than HIV/HCV

    Hepatic steatosis progressed faster and was more often associated with liber fibrosis progression among patients with HIV mono-infection compared with patients with HIV/hepatitis C coinfection, according to recently published data from an ongoing cohort study.

    23 May 2017 | Healio
  • Graphene sensor could speed hepatitis diagnosis

    Researchers in the UK and China are joining forces to develop a graphene-based sensor for on-the-spot diagnosis of hepatitis A, B and C. Particularly useful in areas with a high incidence of the highly infectious liver disease, such as China, the sensor could help stop the spread of hepatitis by speeding up diagnosis and allowing treatment to start more quickly.

    19 May 2017 | The Engineer
  • New Canadian guideline: No screening for hepatitis C in adults not at increased risk

    The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus in adults at low risk in a guideline published in Canadian Medical Association Journal.

    25 April 2017 | Eurekalert Inf Dis
  • Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease

    A multicenter, randomized, controlled study presented today found that long-term oral antibiotic therapy with norfloxacin improved the prognosis of people with life-threatening advanced liver disease. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that norfloxacin administration for six months was associated with a reduced risk of death and infection at six months in patients with Child-Pugh class C cirrhosis, a very severe and advanced stage of liver disease.

    20 April 2017 | EASL press release
  • HCV Infection Linked to Nonhepatic Cancers in the Elderly

    Hepatitis C virus (HCV) infection may be linked to cancers other than hepatocellular carcinoma (HCC), such as bile duct cancers and diffuse large B-cell lymphoma (DLBCL), according to a study published in Cancer.

    21 February 2017 | Infectious Disease Advisor
  • HCV Screening Shouldn't Just Focus on At-Risk Populations

    At the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, researchers from MedStar Health Research Institute in Maryland presented new data on hepatitis C virus (HCV)-positive non-baby boomers.

    21 February 2017 | Contagion Live
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.